The Latest Cardiac and Vascular News
tenacio announces the publication of “Universal Clinician Device for improving risk prediction and management of patients with atrial fibrillation. An assumed benefit analysis” in the European Heart Journal Digital Health The in-silico study demonstrated expected outcome benefits of 23% reduction in mortality, 24% reduction in strokes and 14% in bleeding […]
LAKE OSWEGO, Ore., April 26, 2022 /PRNewswire/ — BIOTRONIK, Inc. announced today it has received U.S. Food and Drug Administration (FDA) approval of Renamic Neo, the company’s state-of-the-art programmer for implanted cardiac rhythm management devices such as ICDs, pacemakers, and implantable cardiac monitors. In addition to its programming functions, Renamic Neo now […]
University of Vermont Medical Center Initiates Evaluation of the ECGenius System as CathVision Prepares for U.S. Launch COPENHAGEN, Denmark, April 26, 2022 /PRNewswire/ — CathVision, a medical technology company developing innovative electrophysiology solutions designed to guide and enhance cardiac ablation therapy through the acquisition of low-noise, high-fidelity electrograms, today announced the completion of patient […]
Access Vascular’s biomaterial catheters recognized as Best New Product in Science & Medical category for their ability to dramatically improve vascular access procedures and outcomes BILLERICA, Mass., April 26, 2022 (GLOBE NEWSWIRE) — Access Vascular, Inc. (AVI) today announced its biomaterial-based hydrophilic catheters received a Gold Award as the 2022 Edison […]
CCM Therapy Addresses an Unmet Clinical Need and Offers Hope to Millions With Heart Failure MARLTON, N.J., April 26, 2022 (GLOBE NEWSWIRE) — Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure (HF), is proud to announce a worldwide milestone achievement as […]
First Quarter 2022 Revenue of $4.1 million, a 43% Increase Over Prior Year MINNEAPOLIS, April 25, 2022 (GLOBE NEWSWIRE) — CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced its financial and operating […]
Launch of capital increase of approximately €15 million for institutional investors with cancellation of the pre-emptive subscription right A minimum of €12 million subscription commitments received from institutional investors, including €10 million from Otium Capital Raise to coincide with pharmaceutical company Julphar acquiring stake in Quantum Genomics via reserved capital […]
Quebec City, Quebec, April 26, 2022 – OpSens Inc. (“OpSens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF), a medical device cardiology-focused company delivering innovative solutions based on its proprietary optical technology, today announced that it has received Health Canada approval for the SavvyWire™, its new guidewire for transcatheter aortic valve replacement procedures, or TAVR. […]
For the first time, heart failure patients can have full visibility of their hearts’ LA pressure and self-adjust their medication to stop further deterioration and avoid hospitalizations April 26, 2022 08:30 AM Eastern Daylight Time TEL AVIV, Israel–(BUSINESS WIRE)–Vectorious Medical Technologies Ltd., today announced that it has enrolled the first […]
PASADENA, Calif.–(BUSINESS WIRE)–Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it has dosed the first patients in the Phase 2 GATEWAY clinical study of investigational ARO-ANG3 for the treatment of patients with homozygous familial hypercholesterolemia (HoFH). ARO-ANG3 is the company’s investigational RNA interference (RNAi) therapeutic designed to silence the hepatic […]
